Biomay (Austria)

Recent papers from Biomay (Austria)

1. Subcutaneous Allergen Immunotherapy With Hypoallergenic Bet v 1 Compared to Conventional Extract: Poorer Blocking Antibody Capacity Dominated by IgG 1 Instead of IgG 4Allergy · 2025
2. Non-Specific Lipid Transfer Protein Amb a 6 Is a Source-Specific Important Allergenic Molecule in Ragweed PollenInternational Journal of Molecular Sciences · 2024
3. Heterogenous Induction of Blocking Antibodies against Ragweed Allergen Molecules by Allergen Extract-Based Immunotherapy VaccinesVaccines · 2024
4. Insect Cell-Expressed Major Ragweed Allergen Amb a 1.01 Exhibits Similar Allergenic Properties to Its Natural Counterpart from Common Ragweed PollenInternational Journal of Molecular Sciences · 2024
5. Relationship between IgE Levels Specific for Ragweed Pollen Extract, Amb a 1 and Cross-Reactive Allergen MoleculesInternational Journal of Molecular Sciences · 2023
6. Complex IgE sensitization patterns in ragweed allergic patients: Implications for diagnosis and specific immunotherapyClinical and Translational Allergy · 2022
7. Time grid-based isomer specific N-glycan analysis and detection of bi-secting Lewis X in human brain2021
8. In vivo Induction of Functional Inhibitory IgG Antibodies by a Hypoallergenic Bet v 1 VariantFrontiers in Immunology · 2020
9. Two years of treatment with the recombinant grass pollen allergy vaccine BM32 induces a continuously increasing allergen-specific IgG4 responseEBioMedicine · 2019
10. Resistance of parvalbumin to gastrointestinal digestion is required for profound and long‐lasting prophylactic oral toleranceAllergy · 2019
11. Rhinovirus Species–Specific Antibodies Differentially Reflect Clinical Outcomes in Health and AsthmaAmerican Journal of Respiratory and Critical Care Medicine · 2018
12. Safety and efficacy of immunotherapy with the recombinant B-cell epitope–based grass pollen vaccine BM32Journal of Allergy and Clinical Immunology · 2018
13. Epicutaneous allergen application preferentially boosts specific T cell responses in sensitized patientsScientific Reports · 2017
14. Comparing Proteolytic Fingerprints of Antigen-Presenting Cells during Allergen ProcessingInternational Journal of Molecular Sciences · 2017
15. Comparison of the immunogenicity of BM32, a recombinant hypoallergenic B cell epitope–based grass pollen allergy vaccine with allergen extract–based vaccinesJournal of Allergy and Clinical Immunology · 2017
16. Amb a 1 isoforms: Unequal siblings with distinct immunological featuresAllergy · 2017
17. Extracorporeal IgE Immunoadsorption in Allergic Asthma: Safety and EfficacyEBioMedicine · 2017
18. Blocking antibodies induced by immunization with a hypoallergenic parvalbumin mutant reduce allergic symptoms in a mouse model of fish allergyJournal of Allergy and Clinical Immunology · 2016
19. Heat-labileEscherichia colitoxin enhances the induction of allergen-specific IgG antibodies in epicutaneous patch vaccinationAllergy · 2016
20. Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergyEBioMedicine · 2016